Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1905-1909

  Nussbaum, Gabriel ^a   Yuan, RuiRong ^a   Casadevall, Arturo ^a   Scharff, Matthew D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BACTERIAL INFECTION; CELL SURVIVAL; COMPETITIVE INHIBITION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGUS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; CRYPTOCOCCOSIS; DRUG INTERACTIONS; FEMALE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN ISOTYPES; MICE; POLYSACCHARIDES;

EID: 0029913815     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1905     Document Type: Article

References (39)

1. Joiner, K.A., R. Scales, K.A. Warren, M.M. Frank, and P.A. Rice. 1985. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J. Clin. Invest. 76:1765-1772.
2. Jarvis, G.A., and J.M. Griffiss. 1991. Human IgA1 blockade of IgG-imtiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule. J. Immunol. 147:1962-1967.
3. Guttman, R.M., and B.A. Waisbren. 1995. Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection. Clin. Exp. Immunol. 19:121-130
4. Hall, W.H., R.E. Manion, and H.H. Zinneman. 1971. Blocking serum lysis of Brucella abortus by hyperimmune rabbit immunoglobulin A. J. Immunol. 107:41-46.
5. Apicella, M.A., M.A. Westerink, S.A. Morse, H. Schneider, P.A. Rice, and J.M. Griffiss. 1986. Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae. J. Infect. Dis. 153:520-526.
6. Rice, P.A., H.E. Vayo, M.R. Tam, and M.S. Blake. 1986. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J. Exp. Med. 164:1735-1748.
7. Casadevall, A. 1995. Antibody immunity and invasive fungal infections. Infect. Immun. 63:4211-4218.
8. Han, Y., and J.E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
9. Currie, B.P., and A. Casadevall. 1994. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis. 19:1029-1033.
10. Pettoello-Mantovani, M., A. Casadevall, T.R. Kollmann, A. Rubinstein, and H. Goldstein. 1992. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet. 339:21-23.
11. Kozel, T.R., and E.G. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol 129:1675-1680.
12. Cherniak, R., E. Reiss, M.E. Slodki, R.D. Plattner, and S.O. Blumer. 1980. Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neofomans serotype A. Mol. Immunol. 17:1025-1032.
13. Kozel, T.R., G.S. Pfrommer, A.S. Guerlain, B.A. Highison, and G.J. Highison. 1988. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev. Infect. Dis. 10(Suppl. 2):S436-S439.
14. Mukherjee, J., G. Nussbaum, M.D. Scharff, and A. Casadevall. 1995. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181:405-409.
15. Yuan, R., A. Casadevall, G. Spira, and M.D. Scharff. 1995. Isotype switching front IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154:1810-1816.
16. Casadevall, A., and M.D. Scharff. 1991. The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide-binding antibodies. J. Exp. Med. 174:151-160.
17. Spira, G., R. Yuan, M. Paizi, M. Weisendal, and A. Casadevall. 1994. Simultaneous expression of kappa and lambda light chains in a murine IgG3 anti-Cryptococcus neoformans hybridoma cell line. Hybridoma. 13:531-535.
18. Rhodes, J.C., L.S. Wicker, and W.J. Urba. 1980. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infecf. Immun. 29:494-499.
19. Mukherjee, J., M.D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-1541.
20. Mukherjee, S., S. Lee, J. Mukherjee, M.D. Scharff, and A. Casadevall. 1994. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect. Immun. 62:1079-1088.
21. Greenspan, N.S., and L.J.N. Cooper. 1993. Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction. Springer Semin. Immunopathol. 15:275-291.
22. Cooper, L.J., D. Robertson, R. Granzow, and N.S. Greenspan. 1994. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance. Mol. Immunol. 31:577-584.
23. Mukherjee, S., S.C. Lee, and A. Casadevall. 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun. 63: 573-579.
24. Rice, P.A., O.P. McQuillen, S. Gulati, D.B. Jani, L.M. Wetzler, M.S. Blake, and E.G. Gorschlich. 1994. Serum resistance of Neisseria gonorrhocae. Does it thwart the inflammatory response and facilitate the transmission of infection? Ann. NY Acad Sci. 730:7-14.
25. Plummer, F.A., H. Chubb, J.N. Simonsen, M. Bosire, L. Slaney, I. Maclean, J.O. Ndinya-Achola, P. Waiyaki, and R.C. Brunham. 1993. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection. J. Clin, Invest. 91:339-343.
26. Hawkes, R.A., and K.J. Lafferty. 1967. The enhancement of virus infectivity by antibody. Virology. 33:250-261.
27. Halstead, S.B. 1979. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140:527-533.
28. Morens, D.M. 1994. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin. Infect. Dis. 19:500-512.
29. Nara, P.L., R.R. Garrity, and J. Goudsmit. 1991. Neutralization of HIV-1: a paradox of humoral proportions. FASEB J. 5:2437-2455.
30. Jones, K.F., and V.A. Fischetti. 1988. The importance of the location of antibody binding in the M6 protein for opsonization and phagocytosis of Group A M6 streptococci. J. Exp. Med. 167:1114-1123.
31. Schreiber, J.R., L.J.N. Cooper, S. Diehn, P.A. Dahlhauser, M.F. Tosi, D.D. Glass, M. Patawaran, and N.S. Greenspan. 1993. Variable region identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysacharide O-specific side chain function differently. J. Infect. Dis. 167:221-226.
32. Louria, D.B., and T. Kaminski. 1965. Passively acquired immunity in experimental cryptococcosis. Sabouraudia. 4:80-84.
33. Graybill, J.R., M. Hague, and D.J. Drutz. 1981. Passive immunization in murine cryptococcosis. Sabouraudia. 19:237-244.
34. Goren, M.B. 1967. Experimental murine cryptococcosis: effect of hyperimmunization to capsular polysaccharide. J. Immunol. 98:914-922.
35. Slack, J., G.P. Der-Balian, M. Nahm, and J.M. Davie. 1980. Subclass restriction of murine antibodies. II. The IgG plaqueforming response to thymus-independant type 1 and type 2 antigens in normal mice and mice expressing an X-hnked immunodefficiency. J. Exp Med. 151:853-862.
36. Cauley, L.K., and J.W. Murphy. 1979. Response of congenitally athymic (nude) and phenotypically normal mice to Cryptoccaus neoformans infection Infect. Immun. 23:644-651.
37. - individuals. Clin. Exp. Immunol. 99:425-432.
38. Sanford, J.E., D.M. Lupan, A.M. Schlageter, and T.R. Kozel. 1990. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect. Immun. 58: 1919-1923.
39. Briles, D.E., J.L. Claflin, K. Schroer, and C. Forman. 1981. Mouse IgG3 antibodies arc highly protective against infection with Streptococcus pneumomae. Nature (Lond ). 294:88-90.